We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Visteon
VC
$2.78B
| $21.8M | 0.05% |
197,457
-17,409
| -8% | -$2.18M |
|
202
Neogen
NEOG
$2.5B
| $21.5M | 0.05% |
642,586
-21,993
| -3% | -$663K |
|
203
Halliburton
HAL
$26.6B
| $21.2M | 0.05% |
451,929
+73,278
| +19% | +$3.62M |
|
|
ILG
204
DELISTED
ILG, Inc Common Stock
ILG
| $21.1M | 0.04% |
679,283
-131,498
| -16% | -$4.12M |
|
|
MLNX
205
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $21.1M | 0.04% |
289,924
-48,240
| -14% | -$3.25M |
|
206
Triumph Financial Inc
TFIN
$1.82B
| $21M | 0.04% |
510,753
-17,166
| -3% | -$672K |
|
|
MRO
207
DELISTED
Marathon Oil Corporation
MRO
| $21M | 0.04% |
+1,299,180
| New | +$21.6M |
|
208
Fortive
FTV
$18.6B
| $20.9M | 0.04% |
426,980
-204,305
| -32% | -$9.72M |
|
209
Norfolk Southern
NSC
$75.1B
| $20.7M | 0.04% |
152,521
-22,178
| -13% | -$3.19M |
|
|
CJ
210
DELISTED
C&J Energy Services, Inc.
CJ
| $20.6M | 0.04% |
799,699
-287,953
| -26% | -$8.22M |
|
|
WCG
211
DELISTED
Wellcare Health Plans, Inc.
WCG
| $20.6M | 0.04% |
106,542
-11,171
| -9% | -$2.24M |
|
|
BKI
212
DELISTED
Black Knight, Inc. Common Stock
BKI
| $20.5M | 0.04% |
435,831
-15,979
| -4% | -$775K |
|
|
TVTY
213
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $20.5M | 0.04% |
517,313
+76,298
| +17% | +$2.96M |
|
214
Marriott Vacations Worldwide
VAC
$4.25B
| $20.4M | 0.04% |
153,186
-9,886
| -6% | -$1.4M |
|
215
Prestige Consumer Healthcare
PBH
$2.6B
| $20.4M | 0.04% |
603,521
+4,493
| +0.8% | +$172K |
|
216
Nasdaq
NDAQ
$52.9B
| $20.3M | 0.04% |
707,655
-59,616
| -8% | -$1.61M |
|
217
Philip Morris
PM
$295B
| $20.3M | 0.04% |
204,273
-33,262
| -14% | -$3.46M |
|
218
Patrick Industries
PATK
$2.85B
| $20.3M | 0.04% |
491,568
-17,405
| -3% | -$751K |
|
219
Travel + Leisure Co
TNL
$4.7B
| $20.2M | 0.04% |
390,230
-75,230
| -16% | -$4.02M |
|
|
WBC
220
DELISTED
WABCO HOLDINGS INC.
WBC
| $20.1M | 0.04% |
150,081
-17,367
| -10% | -$2.52M |
|
221
Agios Pharmaceuticals
AGIO
$1.93B
| $20.1M | 0.04% |
245,613
-8,113
| -3% | -$627K |
|
|
DST
222
DELISTED
DST Systems Inc.
DST
| $20.1M | 0.04% |
240,048
-271,320
| -53% | -$22.1M |
|
223
Korn Ferry
KFY
$4.28B
| $20M | 0.04% |
388,153
-12,095
| -3% | -$538K |
|
|
ALXN
224
DELISTED
Alexion Pharmaceuticals
ALXN
| $20M | 0.04% |
179,292
-3,038
| -2% | -$363K |
|
|
PACW
225
DELISTED
PacWest Bancorp
PACW
| $19.9M | 0.04% |
402,130
+14,564
| +4% | +$761K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.